Sichuan Gangtong Medical Equipment Group Co., Ltd (SHE:301515)
China · Delayed Price · Currency is CNY 20.85
-0.86 (-3.96%)
At close: Jun 2, 2026
SHE:301515 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 746.38 | 720.18 | 751.83 | 840.43 | 766.2 | 678.2 |
Other Revenue | 1.43 | 1.43 | 2.23 | 2.01 | 2.33 | 3.22 |
| 747.81 | 721.61 | 754.06 | 842.44 | 768.53 | 681.41 | |
Revenue Growth (YoY) | 6.49% | -4.30% | -10.49% | 9.62% | 12.78% | 21.14% |
Cost of Revenue | 589.74 | 563.12 | 606.55 | 626.51 | 546.74 | 496.67 |
Gross Profit | 158.08 | 158.5 | 147.51 | 215.93 | 221.79 | 184.75 |
Selling, General & Admin | 75.7 | 73.76 | 70.32 | 77.61 | 76.2 | 69.34 |
Research & Development | 25.52 | 25.99 | 24.25 | 29.87 | 26.47 | 22.35 |
Other Operating Expenses | 5.39 | 5.81 | 5.15 | 5.83 | 4.48 | 3.06 |
Operating Expenses | 173.88 | 171.68 | 147.31 | 149.69 | 139.28 | 108.18 |
Operating Income | -15.81 | -13.19 | 0.19 | 66.24 | 82.51 | 76.57 |
Interest Expense | -6.25 | -6.35 | -6.31 | -4.2 | -4.78 | -4.42 |
Interest & Investment Income | 5.79 | 6.5 | 11.24 | 6.34 | 0.99 | 1.46 |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0 | 0.01 | 0.05 | -0.01 |
Other Non Operating Income (Expenses) | -1.4 | -1.3 | -0.47 | -0.51 | 0.93 | 0.75 |
EBT Excluding Unusual Items | -17.68 | -14.35 | 4.65 | 67.88 | 79.69 | 74.34 |
Gain (Loss) on Sale of Investments | - | - | 0.96 | - | - | - |
Gain (Loss) on Sale of Assets | 0.12 | 0.08 | 0.02 | 17.82 | -0.02 | - |
Asset Writedown | -0 | 0.01 | - | 0.03 | -0.03 | -0.1 |
Legal Settlements | - | - | - | - | -0.27 | -0.22 |
Other Unusual Items | 5.56 | 5.56 | 9.48 | 9.14 | 3.93 | 7.59 |
Pretax Income | -12 | -8.7 | 15.1 | 94.87 | 83.3 | 81.61 |
Income Tax Expense | -3.75 | -3.52 | 0.68 | 11.77 | 9.37 | 9.93 |
Earnings From Continuing Operations | -8.24 | -5.18 | 14.42 | 83.1 | 73.93 | 71.68 |
Minority Interest in Earnings | 3.36 | 2.53 | - | - | - | - |
Net Income | -4.89 | -2.65 | 14.42 | 83.1 | 73.93 | 71.68 |
Net Income to Common | -4.89 | -2.65 | 14.42 | 83.1 | 73.93 | 71.68 |
Net Income Growth | - | - | -82.64% | 12.40% | 3.14% | 9.79% |
Shares Outstanding (Basic) | 96 | 97 | 99 | 85 | 75 | 75 |
Shares Outstanding (Diluted) | 96 | 97 | 99 | 85 | 75 | 75 |
Shares Change (YoY) | -2.82% | -2.73% | 16.20% | 13.89% | -0.00% | 0.00% |
EPS (Basic) | -0.05 | -0.03 | 0.15 | 0.97 | 0.99 | 0.96 |
EPS (Diluted) | -0.05 | -0.03 | 0.15 | 0.97 | 0.99 | 0.96 |
EPS Growth | - | - | -85.06% | -1.31% | 3.14% | 9.79% |
Free Cash Flow | -45.73 | -35.24 | -47.94 | -143.06 | 42.88 | 8.81 |
Free Cash Flow Per Share | -0.48 | -0.36 | -0.48 | -1.68 | 0.57 | 0.12 |
Dividend Per Share | - | - | 0.120 | 0.258 | - | - |
Dividend Growth | - | - | -53.49% | - | - | - |
Gross Margin | 21.14% | 21.96% | 19.56% | 25.63% | 28.86% | 27.11% |
Operating Margin | -2.11% | -1.83% | 0.03% | 7.86% | 10.74% | 11.24% |
Profit Margin | -0.65% | -0.37% | 1.91% | 9.86% | 9.62% | 10.52% |
Free Cash Flow Margin | -6.12% | -4.88% | -6.36% | -16.98% | 5.58% | 1.29% |
EBITDA | -8 | -5.76 | 6.11 | 71.88 | 88.81 | 83.01 |
EBITDA Margin | -1.07% | -0.80% | 0.81% | 8.53% | 11.56% | 12.18% |
D&A For EBITDA | 7.81 | 7.43 | 5.91 | 5.65 | 6.3 | 6.45 |
EBIT | -15.81 | -13.19 | 0.19 | 66.24 | 82.51 | 76.57 |
EBIT Margin | -2.11% | -1.83% | 0.03% | 7.86% | 10.74% | 11.24% |
Effective Tax Rate | - | - | 4.50% | 12.41% | 11.25% | 12.17% |
Revenue as Reported | 747.81 | 721.61 | 754.06 | 842.44 | 768.53 | 681.41 |